# Nutex Health Inc.: Form 10-Q for the period ended Mar 31, 2016

- Company: [Nutex Health Inc.](/companies/nutx.md) (CIK 1479681)
- Form: 10-Q
- Filed: 2016-05-23
- Accepted by EDGAR: May 23, 2016, 16:27 ET
- Period: 2016-03-31
- Accession: 0001211524-16-000233
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1479681/000121152416000233/f2016igambitform_10q1stqtr52.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1479681/000121152416000233/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2016-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2016-01-01 to 2016-03-31 | $403.8k | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months, 2016-01-01 to 2016-03-31 | $3.2k | us-gaap:CostOfRevenue |
| Gross profit | 3 months, 2016-01-01 to 2016-03-31 | $400.6k | us-gaap:GrossProfit |
| Operating income | 3 months, 2016-01-01 to 2016-03-31 | −$158.1k | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2016-01-01 to 2016-03-31 | −$84.3k | us-gaap:InterestExpense |
| Net income | 3 months, 2016-01-01 to 2016-03-31 | −$238.9k | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2016-01-01 to 2016-03-31 | −$0.01 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 3 months, 2016-01-01 to 2016-03-31 | −$285.3k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | at 2016-03-31 | $24.4k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2016-03-31 | $725.1k | us-gaap:AssetsCurrent |
| Total assets | at 2016-03-31 | $7.5m | us-gaap:Assets |
| Current liabilities | at 2016-03-31 | $2.9m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2016-03-31 | $6.1m | us-gaap:Liabilities |
| Shareholders' equity | at 2016-03-31 | $1.3m | us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest |

## Management's discussion and analysis

As filed, 25,740 characters.

### of Operations

### FORWARD LOOKING STATEMENTS

This Form 10-Q includes “forward-looking statements” within the meaning of

Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities

Exchange Act of 1934, as amended. All statements, other than statements of historical

facts, included or incorporated by reference in this Form 10-Q which address activities,

events or developments that the Company expects or anticipates will or may occur in the

future, including such things as future capital expenditures (including the amount and

nature thereof), finding suitable merger or acquisition candidates, expansion and growth

of the Company’s business and operations, and other such matters are forward-looking

statements. These statements are based on certain assumptions and analyses made by the

Company in light of its experience and its perception of historical trends, current

conditions and expected future developments as well as other factors it believes are

appropriate in the circumstances.

Investors are cautioned that any such forward-looking statements are not

guarantees of future performance and involve significant risks and uncertainties, and that

actual results may differ materially from those projected in the forward-looking

statements. Factors that could adversely affect actual results and performance include,

among others, potential fluctuations in quarterly operating results and expenses,

government regulation, technology change and competition. Consequently, all of the

forward-looking statements made in this Form 10-Q are qualified by these cautionary

statements and there can be no assurance that the actual results or developments

anticipated by the Company will be realized or, even if substantially realized, that they

will have the expected consequence to or effects on the Company or its business or

operations. The Company assumes no obligations to update any such forward-looking

statements.

### CRITICAL ACCOUNTING ESTIMATES

Our management’s discussion and analysis of our financial condition and results

of operations are based on our financial statements, which have been prepared in

accordance with accounting principles generally accepted in the United States of

America. The preparation of financial statements may require us to make estimates and

assumptions that may affect the reported amounts of assets and liabilities and the related

disclosures at the date of the financial statements. We do not currently have any estimates

or assumptions where the nature of the estimates or assumptions is material due to the

levels of subjectivity and judgment necessary to account for highly uncertain matters or

the susceptibility of such matters to change or the impact of the estimates and

assumptions on financial condition or operating performance is material, except as

described below.

### Principles of Consolidation

The consolidated financial statements include the accounts of the Company and

its wholly-owned subsidiaries, Wala, Inc. and Gotham Innovation Lab, Inc. All

intercompany accounts and transactions have been eliminated.

### Use of Estimates in the Preparation of Financial Statements

The preparation of financial statements in conformity with generally accepted

accounting principles requires management to make estimates and assumptions that affect

the reported amounts of assets and liabilities and disclosure of contingent assets and

liabilities at the date of the consolidated financial statements and the reported amounts of

revenues and expenses during the period. Actual results could differ from those estimates.

### Fair Value of Financial Instruments

For certain of our financial instruments, including cash, accounts receivable,

prepaid expenses, accounts payable, accrued interest, deferred revenue, and amounts due

to related parties, the carrying amounts approximate fair value due to their short

maturities. Additionally, there are no assets or liabilities for which fair value is

remeasured on a recurring basis.

### Long-Lived Assets

We assess the valuation of components of its property and equipment and other

long-lived assets whenever events or circumstances dictate that the carrying value might

not be recoverable. We base our evaluation on indicators such as the nature of the assets,

the future economic benefit of the assets, any historical or future profitability

measurements and other external market conditions or factors that may be present. If such

factors indicate that the carrying amount of an asset or asset group may not be

recoverable, we determine whether an impairment has occurred by analyzing an estimate

of undiscounted future cash flows at the lowest level for which identifiable cash flows

exist. If the estimate of undiscounted cash flows during the estimated useful life of the

asset is less than the carrying value of the asset, we recognize a loss for the difference

between the carrying value of the asset and its estimated fair value, generally measured

by the present value of the estimated cash flows.

### Revenue Recognition

We recognize revenue from product sales when the following four revenue

recognition criteria are met: persuasive evidence of an arrangement exists, an equipment

order has been placed with the vendor, the selling price is fixed or determinable, and

collectability is reasonably assured. Revenues from maintenance contracts covering

multiple future periods are recognized during the current periods and deferred revenue is

recorded for future periods and classified as current or noncurrent, depending on the

terms of the contracts.

### Deferred Revenue

Deposits from customers are not recognized as revenues, but as liabilities, until

the following conditions are met: revenues are realized when cash or claims to cash

(receivable) are received in exchange for goods or services or when assets received in

such exchange are readily convertible to cash or claim to cash or when such

goods/services are transferred. When such income item is earned, the related revenue

item is recognized, and the deferred revenue is reduced. To the extent revenues are

generated from our support and maintenance services, we recognize such revenues when

services are completed and billed. We received deposits from its various customers that

have been recorded as deferred revenue in the amount of $1,121,667 and $1,190,279 as

of March 31, 2016 and December 31, 2015, respectively.

Gotham’s revenues were derived primarily from the sale of products and services

rendered to real estate brokers. Gotham recognized revenues when the services or

products have been provided or delivered, the fees charged are fixed or determinable,

Gotham and its customers understood the specific nature and terms of the agreed upon

transactions, and collectability was reasonably assured.

### Cash and Cash Equivalents

For purposes of reporting cash flows, cash and cash equivalents include checking

and money market accounts and any highly liquid debt instruments purchased with a

maturity of three months or less.

### Accounts Receivable

We analyze the collectability of accounts receivable from continuing operations

each accounting period and adjust our allowance for doubtful accounts accordingly. A

considerable amount of judgment is required in assessing the realization of accounts

receivables, including the creditworthiness of each customer, current and historical

collection history and the related aging of past due balances. We evaluate specific

accounts when we become aware of information indicating that a customer may not be

able to meet its financial obligations due to deterioration of its financial condition, lower

credit ratings, bankruptcy or other factors affecting the ability to render payment.

Allowance for doubtful accounts was $8,345 at March 31, 2016 and December 31, 2015,

respectively. There was no bad debt expense charged to operations for the three months

ended March 31, 2016 and 2015, respectively.

### Property and equipment and depreciation

Property and equipment are stated at cost. Maintenance and repairs are charged to

expense when incurred. When property and equipment are retired or otherwise disposed

of, the related cost and accumulated depreciation are removed from the respective

accounts and any gain or loss is credited or charged to income. Depreciation for both

financial reporting and income tax purposes is computed using combinations of the straight line and accelerated methods over the estimated lives of the respective assets as follows:

Office equipment and fixtures

5 - 7 years

Computer hardware

5 years

Computer software

3 years

Development equipment

5 years

Depreciation expense of $6,290 and $1,306 was charged to operations for the

three months ended March 31, 2016 and 2015, respectively.

### Goodwill

Goodwill represents the excess of liabilities assumed over assets acquired of

ArcMail and the fair market value of the common shares issued by the Company for the

acquisition of ArcMail. In accordance with ASC Topic No. 350 “Intangibles – Goodwill

and Other”), the goodwill is not being amortized, but instead will be subject to an annual

assessment of impairment by applying a fair-value based test, and will be reviewed more

frequently if current events and circumstances indicate a possible impairment. An

impairment loss is charged to expense in the period identified. If indicators of impairment

are present and future cash flows are not expected to be sufficient to recover the asset’s

carrying amount, an impairment loss is charged to expense in the period identified. A

lack of projected future operating results from ArcMail’s operations may cause

impairment. As the acquisition of ArcMail occurred on November 4, 2015, it is too early

for management to evaluate whether goodwill has been impaired. No impairment was

recorded during the three months ended March 31, 2016.

### Stock-Based Compensation

Stock-based compensation expense for all stock-based award programs, including

grants of stock options and warrants, is recorded in accordance with "*Compensation—*

*Stock Compensation",* Topic 718 of the FASB ASC. Stock-based compensation expense,

which is calculated net of estimated forfeitures, is computed using the grant date fair-

value and amortized over the requisite service period for all stock awards that are

expected to vest. The grant date fair value for stock options and warrants is calculated

using the Black-Scholes option pricing model. Determining the fair value of options at

the grant date requires judgment, including estimating the expected term that stock

options will be outstanding prior to exercise, the associated volatility of the Company’s

common stock, expected dividends, and a risk-free interest rate. Stock-based

compensation expense is reported under general and administrative expenses in the

accompanying consolidated statements of operations.

#### Options

In 2006, we adopted the 2006 Long-Term Incentive Plan (the "2006 Plan").

Awards granted under the 2006 Plan have a ten-year term and may be incentive stock

options, non-qualified stock options or warrants. The awards are granted at an exercise price equal to the fair market value on the date of grant and generally vest over a three or four year period. The Plan expired on December 31, 2009, therefore as of December 31,

2015, there was no unrecognized compensation cost related to non-vested share-based

compensation arrangements granted under the 2006 plan.

The 2006 Plan provided for the granting of options to purchase up to 10,000,000

shares of common stock. 8,146,900 options have been issued under the plan to date of

which 7,157,038 have been exercised and 692,962 have expired to date. There were

296,900 options outstanding under the 2006 Plan on its expiration date of December 31,

2009\. All options issued subsequent to this date were not issued pursuant to any plan.

Stock option activity during the three months ended March 31, 2016 and 2015 follows:

Weighted

Average

Weighted

Remaining

Weighted

Average

Average

Contractual

#### Options

Grant-Date

Life

#### Outstanding

#### Exercise Price

#### Fair Value

#### (Years)

Options outstanding at

December 31, 2014

1,518,900

0.03

0.10

4.76

Options granted

200,000

0.01

0.40

4.98

Options outstanding at

March 31, 2015

1,718,900

0.03

0.13

4.57

Options outstanding at

December 31, 2015

1,718,900

0.03

0.13

3.82

No option activity

Options outstanding at

March 31, 2016

1,718,900

0.03

0.13

3.57

Options outstanding at March 31, 2016 consist of:

Date

Number

Number

Exercise

Expiration

Issued

Outstanding

Exercisable

Price

Date

May 1, 2006

100,000

100,000

$0.01

May 1, 2016

May 1, 2006

100,000

100,000

$0.01

May 1, 2016

May 1, 2006

50,000

50,000

$0.01

May 1, 2016

May 1, 2006

46.900

46,900

$0.01

May 1, 2016

June 9, 2014

213,000

213,000

$0.03

June 9, 2024

June 9, 2014

159,000

159,000

$0.03

June 9, 2024

June 9, 2014

600,000

600,000

$0.03

June 9, 2024

June 6, 2014

250,000

250,000

$0.05

June 6, 2019

March 24, 2015

200,000

200,000

$0.01

March 24, 2020

Total

1,718,900

1,718,900

#### Warrants

In addition to our 2006 Long Term Incentive Plan, we have issued and outstanding

compensatory warrants to two consultants entitling the holders to purchase a total of

275,000 shares of our common stock at an average exercise price of $0.94 per share.

Warrants to purchase 25,000 shares of common stock vest upon 6 months after the

Company engages in an IPO, have an exercise price of $3.00 per share, and expire 2

years after the Company engages in an IPO. Warrants to purchase 250,000 shares of

common stock vest 100,000 shares on issuance (June 1, 2009), and 50,000 shares on each

of the following three anniversaries of the date of issuance, have exercise prices ranging

from $0.50 per share to $1.15 per share, and expire on June 1, 2019. The issuance of the

compensatory warrants was not submitted to our shareholders for their approval.

Warrant activity during the three months ended March 31, 2016 and 2015 follows:

Weighted

(1)Weighted

Weighted

Average Grant-

Average

Date

Remaining

Warrants

Average

#### Contractual

#### Outstanding

#### Exercise Price

#### Fair Value

#### Life (Years)

Warrants outstanding

at December 31, 2014

275,000

0.94

0.10

4.42

No warrant activity

Warrants outstanding

at March 31, 2015

275,000

0.94

0.10

4.17

Warrants outstanding

at December 31, 2015

275,000

0.94

0.10

3.42

No warrant activity

Warrants outstanding

at March 31, 2016

275,000

0.94

0.10

3.17

(2) Exclusive of 25,000 warrants expiring 2 years after initial IPO.

Warrants outstanding at March 31, 2016 consist of:

Date

Number

Number

Exercise

Expiration

Issued

Outstanding

Exercisable

Price

Date

April 1, 2000

25,000

25,000

$3.00

2 years after IPO

June 1, 2009

100,000

100,000

$0.50

June 1, 2019

June 1, 2009

50,000

50,000

$0.65

June 1, 2019

June 1, 2009

50,000

50,000

$0.85

June 1, 2019

June 1, 2009

50,000

50,000

$1.15

June 1, 2019

Total

275,000

275,000

### Stock Transactions

On September 25, 2014, the Board unanimously approved an amendment to the

Company’s Articles of Incorporation to increase the number of shares of Common Stock

which the Company is authorized to issue from seventy five million (75,000,000) to

Three Hundred Million (300,000,000) shares of Common Stock, $0.001 par value per

share, and to create a new class of stock entitled “preferred stock” (together, the

“Capitalization Amendments”). The Capitalization Amendments create provisions in the

Company’s Articles of Incorporation, which allows the voting powers, designations,

preferences and other special rights, and qualifications, limitations and restrictions of

each series of preferred stock to be established from time to time by the Board without

approval of the stockholders. No dividend, voting, conversion, liquidation or redemptions

rights as well as redemption or sinking fund provisions are yet established with respect to

the Company’s preferred stock. On October 3, 2014, the Majority Stockholders executed

and delivered to the Company a written consent approving the Capitalization

Amendments.

#### Common Stock Issued

In connection with the acquisition of Wala, Inc. we issued 11,500,000 common

shares valued at $.10 per share to the president and CEO of Wala, Inc. on November 4,

2015.

We issued 1,000,000 and 600,000 common shares for services, valued at $.20 per

share on August 3, 2015 and May 18, 2015, respectively.

### Income Taxes

We account for income taxes using the asset and liability method in accordance

with ASC Topic No. 740, *Income Taxes.* Under this method, deferred tax assets and

liabilities are determined based on differences between financial reporting and tax bases

of assets and liabilities, and are measured using the enacted tax rates and laws that are

expected to be in effect when the differences are expected to reverse.

We apply the provisions of ASC Topic No. 740 for the financial statement

recognition, measurement and disclosure of uncertain tax positions recognized in the

Company’s financial statements. In accordance with this provision, tax positions must

meet a more-likely-than-not recognition threshold and measurement attribute for the

financial statement recognition and measurement of a tax position.

### INTRODUCTION

iGambit is a company focused on the technology markets. Our sole operating

subsidiary, of Wala, Inc. doing business as ArcMail Technology (ArcMail) is in the

business of providing simple, secure and cost-effective We are focused on expanding the

operations of ArcMail by marketing the company to existing and potential new clients.

***Assets.*** At March 31, 2016, we had $7,466,092 in total assets, compared to

$7,637,996 at December 31, 2015. The decrease in total assets was primarily due to the

decrease in cash, the decrease in prepaid expenses, and the decrease in assets from

discontinued operations.

***Liabilities.*** At March 31, 2016, our total liabilities were $6,143,646 compared to

$6,076,680 at December 31, 2015. Our current liabilities at March 31, 2016 consisted of

accounts payable and accrued expenses of $634,161, accrued interest on notes payable of

$366,255, amounts due to related parties of $82,648, notes payable of $1,106,196,

liabilities from discontinued operations of $23,769 and deferred revenue current portion

of $736,604, whereas our current liabilities as of December 31, 2015 consisted of

accounts payable and accrued expenses of $636,633, accrued interest on notes payable of

$302,278, notes payable of $936,566, amounts due to a related parties of $74,871,

liabilities from discontinued operations of $127,353 and deferred revenue current portion

of $811,227. Our long term liabilities at March 31, 2016 consisted of Notes payable of

$2,808,950 and deferred revenue non-current portion of $385,063, whereas our total

liabilities as of December 31, 2015 consisted of Notes payable of $2,808,950 and

deferred revenue non-current portion of $379,052.

***Stockholders’ Equity.*** Our stockholders’ equity decreased to $1,322,446 at March

31, 2016 from $1,561,316 at December 31, 2015. This decrease was primarily due to an

increase in accumulated deficit from $(2,798,390) at December 31, 2015 to $(3,037,260)

at March 31, 2016, resulting from a net loss of $(238,870) for the three months ended

March 31, 2016.

### THREE MONTHS ENDED MARCH 31, 2016 AS COMPARED TO THREE

### MONTHS ENDED MARCH 31, 2015

***Revenues and Cost of Sales.*** We had $403,750 of revenue during the three

months ended March 31, 2016 compared to revenue from our Gotham subsidiary of

$300,347 during the three months ended March 31, 2015. The increase in revenue was

due primarily to an increase in revenue generated by our ArcMail subsidiary acquired in

November 2015. In addition to ArcMail’s operations, we had income from discontinued

operations of $3,558 and $0 for the three months ended March 31, 2016 and March 31,

2015, respectively.

***General and Administrative Expenses.*** General and Administrative Expenses

increased to $558,653 for the three months ended March 31, 2016 from $307,919 for the

three months ended March 31, 2015. For the three months ended March 31, 2016 our

General and Administrative Expenses consisted of corporate administrative expenses of

$67,686, legal and accounting fees of $39,618, health insurance expenses of $14,720,

directors and officers insurance expenses of $11,136, payroll expenses of $341,478,

consulting expenses of $17,500, marketing expense of $43,990, computer and internet

expense of $15,025 and exchange filing fees of $7,500. For the three months ended

March 31, 2015 our General and Administrative Expenses consisted of corporate

administrative expenses of $85,794, legal and accounting fees of $40,080, health

insurance expenses of $7,688, directors and officers insurance expenses of $10,600,

payroll expenses of $141,041, consulting expenses of $14,498 and exchange filing fees of

$8,218. The increases from the three months ended March 31, 2015 to the three months

ended March 31, 2016 relate primarily to: (i) an increase in payroll expenses; (ii) an

increase in consulting expenses; (iii) an increase in exchange filing fees; and (iv) an

increase in general and administrative costs associated with the operation of our ArcMail

subsidiary. Costs associated with our officers’ salaries and the operation of our ArcMail

subsidiary should remain level going forward, subject to a material expansion in the

business operations of ArcMail which would likely increase our corporate administrative

expenses.

***Other Income (Expense).*** There was interest expense of $84,334 and $1,703 for

the three months ended March 31, 2016 and March 31, 2015, respectively.

### LIQUIDITY AND CAPITAL RESOURCES

### General

As reflected in the accompanying consolidated financial statements, at March 31,

2016, we had $24,375 of cash and stockholders’ equity of $1,322,446 as compared to

$131,987 and $1,561,316 at December 31, 2015. At March 31, 2016 we had $7,466,092

in total assets, compared to $7,637,996 at December 31, 2015.

Our primary capital requirements in 2016 are likely to arise from the expansion of

our Arcmail operations, and, in the event we effectuate an acquisition, from: (i) the

amount of the purchase price payable in cash at closing, if any; (ii) professional fees

associated with the negotiation, structuring, and closing of the transaction; and (iii) post

closing costs. It is not possible to quantify those costs at this point in time, in that they

depend on Arcmail’s business opportunities, the state of the overall economy, the relative

size of any target company we identify and the complexity of the related acquisition

transaction(s). We anticipate raising capital in the private markets to cover any such

costs, though there can be no guaranty we will be able to do so on terms we deem to be

acceptable. We do not have any plans at this point in time to obtain a line of credit or

other loan facility from a commercial bank.

While we believe in the viability of our strategy to improve Arcmail’s sales

volume and to acquire companies, and in our ability to raise additional funds, there can

be no assurances that we will be able to fully effectuate our business plan.

### Cash Flow Activity

Net cash used in operating activities was $285,269 for the three months ended

March 31, 2016, compared to $119,856 for the three months ended March 31, 2015. Our

primary source of operating cash flows from continuing operating activities for the three months ended March 31, 2016 was from our ArcMail subsidiary’s revenues of $403,750 and from our Gotham subsidiary’s revenues $300,347 for the three months ended March

31, 2015. Additional contributing factors to the change were from an increase in

accounts receivable of $99,500, an increase in employee advances of $1,600, a decrease

in prepaid expenses of $50,412, a decrease in accounts payable and accrued expenses of

$2,472, an increase in accrued interest of $63,977, and a decrease in deferred revenue of

$68,612. Net cash provided by discontinued operating activities was $8,664 for the three

months ended March 31, 2016 and s $0 for the three months ended March 31, 2015. The

$8,644 cash provided by discontinued operations for the three months ended March 31,

2016, represents cash payments received from VHT which was offset by a decrease in

accounts receivable included in the Assets from Discontinued Operations.

Cash used in investing activities was $0 or the three months ended March 31, 2016

and $5,026 for the three months ended March 31, 2015. For the three months ended

March 31, 2015 the use of cash from investing activities was from the purchase of

property and equipment of $5,026.

Cash provided by financing activities was $177,657 for the three months ended

March 31, 2016 compared to $30,180 for the three months ended March 31, 2015. The

cash provided by financing activities for the three months ended March 31, 2016

consisted of an increase in notes payable of $169,880 and amounts due to related parties

of $7,777 whereas the cash provided by financing activities for the three months ended

March 31, 2015 consisted of proceeds from loans from shareholders of $30,180.

### Supplemental Cash Flow Activity

In the three months ended March 31, 2016 the company paid interest of $2,927

compared to interest of $1,703 in the three months ended March 31, 2015.

## Controls and procedures

As filed, 919 characters.

### Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures

We carried out an evaluation, as required by paragraph (b) of Rule 13a-15 and

15d-15 of the Exchange Act under the supervision and with the participation of our

management, including our Chief Executive Officer and Chief Financial Officer, of the

effectiveness of our disclosure controls and procedures, as defined in Rules 13a-15(e) and

15d-15(e) under the Exchange Act as of March 31, 2012. Based upon that evaluation,

our Chief Executive Officer and Chief Financial Officer concluded that our disclosure

controls and procedures were effective as of March 31, 2015.

### Change in Internal Controls

During the quarter ended March 31, 2015, there were no changes in our internal control over

financial reporting that materially affected, or are reasonably likely to materially affect, our internal control

over financial reporting.

Filed May 23, 2016.
Source: SEC EDGAR, the filing index for accession 0001211524-16-000233. Last ingested by Listed: Nov 14, 2026, 12:46 ET. No prices; not investment advice.
